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Abstract
Natural products obtained from species of the genus Abuta (Menispermaceae) are known
as ethnobotanicals that are attracting increasing attention due to a wide range of their phar-
macological properties. In this study, the alkaloids stepharine and 5-N-methylmaytenine
were first isolated from branches of Abuta panurensis Eichler, an endemic species from the
Amazonian rainforest. Structure of the compounds was elucidated by a combination of 1D
and 2D NMR spectroscopic and MS and HRMS spectrometric techniques. Interaction of the
above-mentioned alkaloids with acetylcholinesterase enzyme and interleukins IL-6 and IL-8
was investigated in silico by molecular docking. The molecules under investigation were
able to bind effectively with the active sites of the AChE enzyme, IL-6, and IL-8 showing
affinity towards the proteins. Along with the theoretical study, acetylcholinesterase enzyme
inhibition, cytotoxic, and immunomodulatory activity of the compounds were assessed by in
vitro assays. The data obtained in silico corroborate the results of AChE enzyme inhibition,
the IC50 values of 61.24μM for stepharine and 19.55μM for 5-N-methylmaytenine were
found. The compounds showed cytotoxic activity against two tumor cell lines (K562 and
U937) with IC50 values ranging from 11.77 μM to 28.48 μM. The in vitro assays revealed
that both alkaloids were non-toxic to Vero and human PBMC cells. As for the immunomodu-
latory activity, both compounds inhibited the production of IL-6 at similar levels. Stepharine
inhibited considerably the production of IL-8 in comparison to 5-N-methylmaytenine, which
showed a dose dependent action (inhibitory at the IC50 dose, and stimulatory at the twofold
IC50 one). Such a behavior may possibly be explained by different binding modes of
the alkaloids to the interleukin structural fragments. Occurrence of the polyamine alkaloid
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5-N-methylmaytenine was reported for the first time for the Menispermaceae family, as well
as the presence of stepharine in A. panurensis.
Introduction
Menispermaceae family has a wide geographic distribution, mainly in tropical and subtropical
regions of the world; its name is related to a crescent moon shape of the seeds [1, 2]. The genus
Abuta is native to tropical Central and South America, where it is represented by more than 30
species. Some of them have been used by indigenous people to prepare curare, alkaloid-con-
taining arrow and dart head poisons that paralyze the prey [1, 3].
As a result, the Menispermaceae family have been in a focus of rising interest to study sev-
eral classes of secondary plant metabolites, including alkaloids; which are rather abundant
constituents [4–11]. Several classes of alkaloids were isolated from Abuta, those include: iso-
quinoline [12, 13], benzylisoquinoline [12, 14], benzyltetraisoquinoline [15], bisbenzyltetraiso-
quinoline [15–17], aporphine [18], and proaporphine [12, 15] derivatives; as well as other less
frequent ones such as tropolone-isoquinoline, azafluoranthene, and benzazepine alkaloids [19,
20]. Those alkaloids reveal a wide range of pharmacological activities including muscle relax-
ant [1], antiplasmodial [14], inhibitory for acetylcholinesterase (AChE) and butyrylacetylcholi-
nesterase enzymes [17, 21, 22], cytotoxic [19, 23, 24], and immunomodulatory [25].
A stepharine is one of the most representative proaporphine alkaloids in Menispermaceae
family; it was first identified in the genus Stephania [26]. Proaporphine alkaloids are princi-
pally known for their potential to inhibit reversibly the acetylcholinesterase enzyme [27, 28].
Effectiveness and anti-AChE potential of the stepharine sulfate salt (stephaglabine) was
reported for the treatment of traumatic and postoperative injuries of the peripheral nervous
system and confirmed by a clinical study [29]. However, a pharmaceutical potential of stephar-
ine is much wider according to the literature reports [30, 31]. It showed a cytotoxic activity
against two human lung cancer cell lines [32], as well as a weak antifungal potential and DNA-
damaging activity [30]. Therefore, both isolation of stepharine from plants cell cultures and
several synthetic procedures were developed to satisfy a growing need for the medicinal use of
the compound [31, 33].
Polyamine alkaloids (the derivatives of putrescine, spermidine, spermine, and cadaverine)
are metabolites that occur widely in angiosperm plants [34–37], but are practically absent in
sterile ones [35, 37–42]. Those compounds may also be isolated from other natural sources
[43], particularly from fungi [44–48]. The polyamine alkaloids are not common for the Menis-
permaceae family, they were reported only for a Cissampelos genus [37, 49]. Cinnamoyl deriva-
tives of polyamine alkaloids inhibit the AChE and α-glucosidase [38, 50, 51]. Alongside, they
also inhibited cancer cell growth [46, 48, 52] and revealed an antiviral activity [53]. In the
Amazon region, a polyamine alkaloid N,N’-di-E-cinnamoylspermidine or maytenine was iso-
lated fromMaytenus krukovii (Maytenus chuchuhuasha) trees (Celastraceae) [46, 54]. Several
studies have stimulated the development of synthetic approach to that class of polyamides [46,
55–58] including the maytenine synthesis [59].
In the present study, 5-N-methylmaytenine (1) and the stepharine (2) were isolated for the
first time from A. panurensis. This is also the first report on the occurrence of (1) in Menisper-
maceae family. Interactions of the alkaloids in question with acetylcholinesterase (AChE)
enzyme and cytokines IL-6 and IL-8 were investigated in silico by molecular docking. The
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potential of (1) and (2) as AChE inhibitors, antitumor and immunomodulatory agents was
demonstrated by in vitro studies.
Materials and methods
Chemicals
Reagents and HPLC-grade solvents were purchased from Tedia Company (Fairfield, OH,
USA) and Sigma-Aldrich and used as supplied. P.A. (Nuclear) grade solvents were purified by
standard procedures used in natural products chemistry. An ultrahigh-purity water was
obtained by Milli Q system (Millipore, Bedford, MA, USA).
Plant material
The authors declare that a specific permission from the National Institute of Amazonian
Research (INPA) was required to collect plant material. The authors got the permission No.
35/12 of 02.12.2017 and confirm that the study did not involve endangered or protected spe-
cies. A. panurensis plant material was collected at the Adolpho Ducke Forest Reserve, 26 km
along the AM-010 highway from the city of Manaus, the State of Amazonas, Brazil. The species
under investigation had been identified by the taxonomist L.S.Mergulhão. The voucher speci-
mens were deposited in the Herbarium of the National Institute of Amazonian Research
(INPA) under the voucher no 279373. The access to genetic heritage was registered at the
National System of Genetic Heritage and Associated Traditional Knowledge Management
(SisGen, Brazil) under the code number A9CC956.
The branches collected were dried at room temperature (ca. 20˚C) for 10 days. Subse-
quently, the vegetal material (1.4 kg of branches) was crushed in a knife mill and stored in a
refrigerator until use.
Extraction
Dried and crushed plant material was subjected to an acid-base extraction [60]. The crushed
branches (300g) were macerated with a 10% solution of NH4OH (2L) and CH2Cl2 (2L) at
room temperature (20˚C) for 72h, the material was stirred every 24 hours. The organic phase
(1.5L) was transferred to a separatory funnel with a 10% solution of acetic acid (2L) and stirred
manually. Then, the acidic aqueous phase was transferred to another vessel and the pH was
adjusted to 10 using NH4OH and extracted with CH2Cl2 (2 × 300mL). The CH2Cl2 phase was
separated, concentrated on a rotary evaporator under reduced pressure, and dried with anhy-
drous sodium sulfate, resulting in the alkaloid fraction (280mg).
LC-APCI-MS analysis
LC-APCI-MS analyzes were performed on an Acella chromatograph (Thermo Scientific); cou-
pled to a triple-quadrupole mass spectrometer model TSQ Quantum Acess1 (Thermo Scien-
tific), equipped with an Atmospheric Pressure Chemical Ionization (APCI) source, operated
in positive mode with monitoring in the range ofm/z 100–800. The mass spectrometer was
equipped with Surveyor LC Pump Plus, Surveyor Autosampler Plus, Rheodyne injection valve
(25μL), Luna C18 column (150 × 4.60mm, 5μm) (Phenomenex–Torrance, CA, USA), operat-
ing simultaneously with Surveyor PDA Plus diode array detector (DAD). The mobile phase
was composed of B (methanol) and A (formic acid 1% v/v in H2O) with a linear elution gradi-
ent: 0–20 min 20–80% B, 20–35 min 80% B, 35–45 min 20–80% B. The flow rate of the mobile
phase was 1 mL/min and the injection volume was 10μL. The DAD detector was set up for
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monitoring between 200-400nm. The spectra were processed using an Xcalibur software (ver-
sion 2.2).
Semi-preparative HPLC analysis
Isolation of the alkaloids was performed on a semi-preparative scale on a Shimadzu chromato-
graph composed of a CBM-20A communication module, SPD-20AV UV detector, DGU-
20A5 degasser, LC-6AD pump, 200 μL Rheodyne injection valve, and Luna C18 column (250
x 15.00mm, 5μm) (Phenomenex–Torrance, CA, USA) with a flow rate of 3 mL/min. The
mobile phase was composed of B (methanol) and A (formic acid 1% v/v in H2O), with a linear
elution gradient: 0–20 min 20–80% B, 20–35 min 80% B, 35–45 min 20–80% B. The UV detec-
tor was set to monitoring at 260nm and 280nm. Fractions containing 5-N-methylmaytenine
(11.2mg—1) and stepharine (22.1mg—2) were collected and analyzed by high-resolution mass
spectrometry (HRMS) and NMR spectroscopy.
High resolution mass spectrometry
HRMS analyses were performed on a Shimadzu chromatograph composed of a CBM-20A
communication module, a SPD-20AV UV detector, a LC-20AD pump, a SIL-20A HT auto-
sampler (200μL), a CTO-20A oven, and a Luna PFP column (150 x 2mm, 100A); coupled to a
Bruker microTOF-QII mass spectrometer, equipped with an Atmospheric Pressure Chemical
Ionization (APCI) source, operated in a positive mode. The instrument parameters were as fol-
lows: capillary voltage, 4500V; nebulizer pressure (N2), 4.0 bar; dry gas flow (N2), 8L/min; dry
heater temperature, 200˚C; with a monitoring in the range ofm/z 100–800 Da. The mobile
phase was composed of B (formic acid 0.1% v/v in methanol) and A (formic acid 0.1% v/v in
H2O) with a linear elution gradient as follows: 0–2 min 20–80% B; 2–42 min 100% B. The flow
rate of the mobile phase was set to 0.2 mL/min and the injection volume was 10μL. The UV
detector was set up for monitoring between 254nm and 330nm. The spectra were processed
using a Bruker Compass Data Analysis software (version 4.2).
1D and 2D NMR spectroscopy
NMR spectra were recorded on a Bruker Avance IIIHD spectrometer, 500.13 MHz for 1H and
125.0 MHz for 13C operated at a magnetic field strength of 11.7 Tesla, equipped with a 5 mm
direct detection PA BBO BBF HD-05-Z SP Intelligent probe incorporating Z-axis gradient
coil, capable of providing gradient amplitudes up to 50 G/cm. Shigemi’s 5.0 mm NMR tubes
were used. For structural elucidation, the samples of 5-N-methylmaytenine and stepharine
were solubilized in 600 μL of DMSO-d6 (δH 2.50, δC 39.9) and CD3OD (δH 3.34, δC 49.8),
respectively. The acquisition of 1H, 13C, DEPT 135, COSY, HSQC, and HMBC spectra was
performed using standard Bruker pulse sequences. The analysis based on 1H NMR data was
performed by solubilizing 10.0 mg of the 5-N-methylmaytenine in 550 μL of DMSO-d6 with
50 μL of TMS (0.5 mM, 98%, Tokyo Chemical Industry) and 15.0 mg of the stepharine in
550 μL of CD3OD with 50 μL of TMS (0.5 mM, 98%, Tokyo Chemical Industry) at 25 ˚C.
Acquisition of 5-N-methylmaytenine and stepharine spectra was performed using the zg30
pulse sequence with water signal suppression, data points of the 64 kB time domain, 10 kHz
spectral width, 1.00 second relaxation delay (D1), 3.27 second acquisition time (AQ), 32 scan
numbers with DS of 2, decomposition resolution of 0.31 Hz, a constant receiver gain at 161 (5-
N-methylmaytenine) and 181 (stepharine) with displacement frequency set at 2,425.23 Hz,
PLW1 of 20.3 W. The calibration pulse (P1 9.400 μs to 5-N-methylmaytenine and P1 10.300 μs
to stepharine) with PLW9 were of 7.183×10−5 W (5-N-methylmaytenine) and 8.6243×10−5 W
(stepharine). Data were processed using Bruker1 Topspin 4.0.6 software.
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Molecular docking calculations
Ligand structures preparation. Ligand structures were built manually and preliminary
optimized in a classic molecular mechanics software. In order to use equilibrium ligand struc-
tures, their geometry optimizations were conducted using a semi-empirical PM7 level [61]
within the MOPAC program [62]. Ligand structure files for docking were prepared using
AutoDock Tools [63, 64]. Default settings for the detection of rotatable bonds were used.
Protein files preparation. X-ray structures of the proteins under investigation (AChE,
PDB ID: 6H12; IL-6, PDB ID: 4NI7 and IL-8, PDB ID: 3IL8) were obtained from the RCSB
Protein Data Bank.Missing residues. Modeling of missing residues in the protein structures
was performed using Modeller web-service [65]. Obtained structures that do not possess seri-
ous structural issues were selected for docking studies. Clashes or contacts between the side
chains of the produced structures were resolved by minimization routine implemented in
UCSF Chimera [66].Water molecules are commonly found in the XRD structures of proteins
and can have substantial impact on the docking affinities. Selection of water molecules that
could be important in docking was performed according to the distance criterion. All water
molecules farther than 3.3 Å from the H-bond donors and acceptors in the protein structures
were removed. Protonation of the oxygen atoms in water molecules was made in UCSF Chi-
mera followed by minimization of the hydrogen positions.
Binding sites of the proteins were identified using Discovery Studio Visualizer [67]. Auto-
Dock Tools [63,64] were used for the preparation of Structure files for docking.
Docking runs. Docking studies were performed with AutoDock Vina program [68]. The
protein structures stayed rigid during the docking in all cases. Each run generated nine bind-
ing poses. Exhaustiveness parameter of 50 was used for the medium search space sizes, e.g.
for the binding pocket in AChE. In the case of larger search spaces (IL-6, IL-8) exhaustiveness
of 500 was used. Since the success of a docking run depends on a random seed, which is
defined at the beginning of the run and does not change during it; we have performed three
docking runs for each protein-ligand pair and search space. The best docking poses found
were similar between the runs in most cases, showing that the chosen parameters provided
exhaustive search of the conformational space.Missing residues. Selected protein structures
from Modeller service were used for the estimation of binding to the regions that were miss-
ing in the initial XRD structures. Search spaces that include the modeled parts of the protein
were chosen.Water molecules. It is known that inclusion of all water molecules in the dock-
ing run can lead to erroneous results [69]. Therefore, trial docking runs were performed with
an inclusion of one of the crystallization water molecules found in the XRD structures at a
time. The water molecules were fixed during the docking run. The search space either cov-
ered the defined binding site of the protein or was centered on the water molecule and had a
size of 20×20×20 Å.
Protein structure images were obtained using Discovery Studio Visualizer [67], PyMOL
[70], and UCSF Chimera [66]. Detailed docking parameters are collected in the S1 File.
Acetylcholinesterase inhibition assay
Acetylcholinesterase enzyme from an electric ray Tetronarce californica (Sigma-Aldrich, USA)
was used for the experiments. The in vitro AChE inhibition assay was performed in 96-well
microplates according to the methodology proposed by Ellman et al. [71] (1961) and Senol
et al. [72] (2015) with some modifications. The alkaloids were tested at concentrations of 2.8;
5.6; 11.2; 22.5; 45.0 and 90.0 μg/mL. Initially, 20 μL of each sample from the stock solution (1
mg/mL) were added and serial dilutions were performed. Then, 150 μL of a sodium phosphate
buffer pH = 8 (0.1 mM), 20 μL of 5,5´-dithio-bis(2- nitrobenzoic)acid (DTNB, 0.0025 M), and
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20 μL of the acetylcholinesterase enzyme (1 U/mL) were added subsequently to each well at 25
˚C and left for 15 minutes. The reaction was initiated by addition of 10 μL of acetylcholine
iodide (AChI) (0.1 M). Neostigmine (0.28–9.0 μg/mL) was used as a positive control.
A thiocholine formed by the enzymatic hydrolysis of the AChI, reacts with the DTNB giv-
ing rise to yellow 5-mercapto-2-nitrobenzoate anion. Concentration of the latter in each well
was measured as absorbance at 405 nm using a 96-well microplate reader spectrophotometer
(Biotek model ELX800). The transformation was monitored for 30 min at 5 min intervals.
Inhibition curve was plotted as the inhibition percent vs concentration. All assays were per-
formed in triplicate.
Cytotoxicity assay
The cytotoxicity of the alkaloids to different cell lines was evaluated by MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell proliferation assay. The fol-
lowing cell lines were used for the evaluation: K562 (human chronic myelogenous leukemia,
ATCC1 CCL-243™), U937 (human histiocytic lymphoma, ATCC1 CRL-1593.2™), HL60
(human acute promyelocytic leukemia, ATCC1 CCL-240™), Vero (kidney epithelial cells
extracted from an African green monkey Chlorocebus sp., ATCC1 CCL-81™), and human
peripheral blood mononuclear cells (PBMC) from healthy blood donors. The cell lines K562,
HL60, and U937 were kindly donated by Prof. S.O. Saad (Hematology and Hemotherapy Cen-
ter at the National Institute of Blood Science and Technology of the University of Campinas,
Campinas, São Paulo, Brazil). The Vero cells were kindly donated by Prof. F.Naveca (Labora-
tory of Infectious Disease Ecology in the Amazon, L. and M.Deane Institute, FIOCRUZ,
Manaus, Amazonas, Brazil). The cells were cultured in 96-well plates. An amount of 2×104
cells was seeded into each well containing 0.2 mL of a RPMI medium supplemented with 10%
FBS, penicillin-streptomycin and fungizone, in an atmosphere of 5% CO2 at 37˚ C for 24
hours. After a formation of sub-confluent monolayer, the cells were treated with different con-
centrations of the alkaloids (12 . . . 100 μg/mL) and incubated again at the same conditions for
24, 48, and 72 hours. Sterile PBS and DMSO 100% were used as negative and positive controls,
respectively. Subsequently, the medium was removed from all wells and 10 μL of the MTT (5
mg/mL in sterile PBS) diluted in 100 μL of a DMEM medium (without phenol red to avoid
misinterpretation) was added into the wells and incubated for 4 hours at the same conditions
mentioned above. After that, the MTT was removed and 50 μL of the MTT lysis buffer were
added to each well. The plate was homogenized gently to dissolve the formazan crystals and
incubated for 10 minutes at 37 ˚C. Optical densities of the samples at wavelength of 570 nm
were measured using a microplate reader. The relative viability of the cells was estimated using
the following equation:
A570 of treated sample
A570 of untreated sample
� 100;
where A570 is the absorbance at 570nm. All assays were done in triplicate.
Immunological assay
To analyze the immunomodulatory potential, human peripheral blood mononuclear cells
(PBMCs) obtained from healthy blood donor candidates were cultured in RPMI-1640 medium
in a 96-well plate and incubated for 24h with 5-N-methylmaytenine (12.5 μM and 25 μM) or
stepharine (28.48 μM and 57.0 μM). After the incubation, the supernatants were collected for
cytokine assays. The supernatant of untreated PBMC cells was used as control. The concentra-
tions of IL-6 and IL-8 cytokines were evaluated by commercially available enzyme-linked
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immunosorbent assay (ELISA) kits (Boster, Pleasanton, CA, USA). The results were normal-
ized for protein levels contained in each sample and were expressed in pg/mg of total protein.
The assays were repeated in triplicate for each individual sample using untreated cells as nega-
tive control. This study was approved by the Committee for Ethics in Research on Human
Beings of the HEMOAM (approval number: 3.138.343).
Statistical analysis
Statistical analysis was performed with GraphPad Prism 7.01 software using Student’s t-test
and ANOVA. A probability value of less than 0.05 was chosen as a statistical significance
criterion. Throughout the text, the asterisks correspond to the following probability values:
� means p<0.01; �� means p< 0.001; and ��� means p<0.0001, when compared to the negative
control (untreated cells). The half maximum inhibitory concentration IC50 values were calcu-
lated using nonlinear regression.
Results
Spectral data
5-N-methylmaytenine (1) was isolated as a light yellow amorphous solid (11.2 mg). 1H NMR
(500 MHz, DMSO d6, TMS): δ 8.12 (t; 2H; J = 5.5 Hz, 1 and 10-NH), δ 7.56 (m, 2H, 5´-H and
5´´-H or 9´-H and 9´´-H), δ 7.54 (m, 2H, 9´-H and 9´´-H or 5´-H and 5´´-H), δ 7.55 (m, 2H,
6´-H, 6´´-H, 8´-H, 8´´-H), δ 7.40 (m, 2H, 7´-H and 7´´-H), δ 7.42 (m, 1H, 3´-H or 3´´-H), δ
7.38 (m, 1H, 3´´-H or 3´-H), δ 6.63 (d, 1H, 2.4 Hz, 2´-H or 2´´-H), δ 6.60 (d, 1H, 2.4 Hz, 2
´´-H or 2´-H), δ 3.20 (m, 2H, 2-H), δ 3.18 (m, 2H, 9-H), δ 2.35 (m, 2H, 4-H), δ 2.32 (m, 2H,
6-H), δ 2.16 (s, 3H, 5-NCH3), δ 1.61 (m, 2H, 3-H), δ 1.47 (m, 2H, 8-H), δ 1.45 (m, 2H, 7-H).
13C NMR (125 MHz, DMSO d6, TMS): δ 165.32; 165.27; 135.43; 127.98; 127.94, 129.39; 129.83;
138.85; 138.88; 122.79; 122.83; 55.26; 57.12; 42.09; 37.58; 39.07; 27.28; 24.53; 27.48 ppm. (S1
Table in S1 File). MS (APCI+)m/z 420 [M+H]+: 202, 188, and 131. HRMSm/z 420.2669 (calc.
for C26H34N3O2m/z 420.2646, Δm/z theor. = -5.6 ppm).
Stepharine (2) was isolated as a light brownish amorphous solid (22.1mg). 1H NMR (500
MHz, CD3OD, TMS): δ 7.01 (dd, 1H, 3 and 10Hz, 12-H), δ 7.16 (dd, 1H, 3 and 10Hz, 8-H), δ
6.89 (s, 1H, 3-H), δ 6.41(dd, 1H, 1.8 and 10Hz, 11-H), δ 6.29 (dd, 1H, 1.8 and 10Hz, 9-H), δ
4.72 (m, 1H, 6a-H), δ 3.82 (s, 3H, 2-OCH3), δ 3.70 (ddd, 1H, 1.5, 6.3 and 13Hz, 5-H), δ 3.61 (s,
3H, 1-OCH3), δ 2.52 (dd, 1H, 6.6 and 12 Hz, 7-H), δ 2.42 (dd, 1H, 10.5 and 12Hz, 7‘-H), δ 3.44
(ddd, 1H, 6.3, 11 and 13Hz, 5-H), δ 3,02 and δ 3,00 (m, 2H, 4-H), δ 1.95 (s, 1H, NH) ppm. 13C
NMR by HSQC (125 MHz, CD3OD, TMS): δ 153.63; 150.28; 112.15; 127.81; 126.74; 56.48;
55.37; 43.71; 59.95, 44.90; 43.71; 23.5 ppm. (S2 Table in S1 File). MS (APCI+)m/z 298 [M+H]+:
281, 266, 250, 235, 161. HRMSm/z 298.1461 (calc. for C18H20NO3m/z 298.1438, Δm/z theor. =
-7.9 ppm).
Binding with acetylcholinesterase of Tetronarce californica (TcAChE)
X-ray structure of the AChE from the electric ray T. californica was found in the RCSB Protein
Data Bank under 6H12 code [73]. The crystal structure retrieved from the Data Bank repre-
sents the AChE adduct with a functionalized urea ligand. In order to verify robustness of the
method, preliminary docking studies were conducted using the ligand structures obtained
from the experimental XRD data. The best affinity of the ligand without the inclusion of water
molecules reached -15.3 kcal/mol with a RMSD value of 4.03 Å compared to the ligand pose
found in the crystal structure. Relatively high RMSD value can be explained by substantial
internal mobility of the ligand molecule. Inclusion of 18 crystallization water molecules
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increased the affinity value to -14.0 kcal/mol with comparable RMSD. In the case of fully
hydrated pocket, many binding poses were found with similar affinity values, ranging from
-13 to -14 kcal/mol. Some of those conformations showed better RMSD values reaching 2.2 Å.
Screening of the water molecules failed to achieve interaction energies lower than those
obtained for the empty binding pocket. Therefore, water molecules do not seem to play a sub-
stantial role in the binding of the urea ligand. Still, there was a possibility that hydration could
be important for interactions with stepharine or 5-N-methylmaytenine. Therefore, it was con-
sidered for those ligands as well.
Two major binding sites were identified in the AChE structure–the main active site and the
region near the modeled C-terminal loop (Fig 1). Consequently, we have conducted docking
studies of these sites and a rear region that can possess smaller pockets (S32–S37 Figs in S1 File
and the accompanying information).
Neostigmine is known as an efficient AChE inhibitor that was used as positive control in
this study. According to the neostigmine docking results, the best affinity value was achieved
for the main cavity of the enzyme and reaches -7.6 kcal/mol. The binding energies for the
other sites were weaker by ca. 2 kcal/mol. Inclusion of water molecules did not produce any
pronounced effect on the affinities and changed them by ca. 0.5 kcal/mol (S31 Fig in S1 File
and the accompanying information).
5-N-methylmaytenine (1) preferably binds to the AChE active site with the affinity of -10.5
kcal/mol. Stepharine (2) fits well inside the AChE active site with the predicted binding affinity
of -10.3 kcal/mol. Affinities of both ligands to the other sites were weaker by 2 . . .4 kcal/mol.
Explicit inclusion of water molecules into the binding cavity had little effect on the binding
strengths (S31 Fig in S1 File and the accompanying information).
Binding with interleukin-6
X-ray structure of human interleukin-6 (PDB ID: 4NI7) was used for the docking studies [74].
The structure contains a co-crystallized nucleic acid moiety that was removed prior to dock-
ing. During the signaling event, the IL-6 associates with the IL-6 receptor (IL-6r) and forms a
complex. Then, the second receptor protein, viz. the gp130 glycoprotein, binds to the complex
giving rise to a dimer; and the signaling is initiated [74–76]. X-ray structure of the interleukin-
receptor complex (Fig 2B) was retrieved from the RCSB PDB (ID: 1P9M) [76].
According to the original paper [74], the IL-6 molecule possesses three binding sites, where
the interactions with the receptor proteins and the second IL-6 molecule occur (Fig 2A). IL-6
–IL-6r interaction takes place at the Site 1, whereas the IL-6 interacts with the gp130 at the
Sites 2 and 3. The IL-6 molecule does not have an apparent binding pocket. Four small binding
pockets at the Sites 1 and 2 and several smaller pockets at the upper rim of the protein were
identified. Since the pocket volume has never exceed 42 Å3, the entire protein surface was con-
sidered for the docking calculations.
The strongest affinity of -7.9 kcal/mol was found for 1, when the ligand interacted with two
helices and a modeled loop at the IL-6 upper rim. Several other binding modes employed an
interaction with a side surface of the two helices, including a π-stacking with both 5-N-methyl-
maytenine phenyl rings as well. Water molecules had also been screened for possible interac-
tions with the docked ligand, but no significant effect was found (p 45 of the S1 File).
Stepharine (2) binds to the IL-6 with the affinity of -6.9 kcal/mol at the same site as 5-N-
methylmaytenine. Again, water molecules did not provide any additional binding strength (p
45 of the S1 File).
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Interleukin-8
The crystal structure of the interleukin-8 was retrieved from the RCSB protein data bank (PDB
ID: 3IL8) [77]. It is known that IL-8 interaction with the appropriate receptors (CXCR1 and
CXCR2) involves two sites close to the N-terminus (Fig 3) [78–80]. The N-loop designated as
Site I includes the residues from Ser14 to Lys20. The Site II is comprised of Glu4-Leu5-Arg6
(‘‘ELR”) residue sequence. During the signaling event, the Site I interacts with the receptor N-
terminal residues while the Site II is involved in the interaction with the receptor extracellular
residues [78]. Two other important regions of the protein structure comprise lateral sides of
the α-helix and the β-strand involved in the IL-8 dimer formation.
Fig 1. Two major binding sites found for AChE. Other, smaller sites are not shown.
https://doi.org/10.1371/journal.pone.0239364.g001
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No binding sites were identified by the Discovery Studio routines. Both the IL-8 monomer
and dimer were employed in the docking studies. Due to a moderate size of the interleukin
molecule, the entire surface of the protein was included into the search space. 5-N-methylmay-
tenine (1) interacts with the IL-8 monomer and dimer with the affinities of -6.9 and -7.0 kcal/
mol, respectively. Stepharine (2) interacts with the monomeric and dimeric forms of the IL-8
Fig 2. Binding sites of the IL-6 according to [74] (A) and IL-6 receptor complex 1P9M (B). In Fig 2B, the IL-6 structures are beige, the gp130
is marked red, and the IL-6r is green.
https://doi.org/10.1371/journal.pone.0239364.g002
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with the similar affinity of -5.9 kcal/mol. Screening of the water molecules did not improve the
binding strengths (S38 and S39 Figs in S1 File and accompanying information).
Acetylcholinesterase inhibition assay
The inhibitory activity of 5-N-methylmaytenine and stepharine towards the AChE enzyme
showed the inhibition percentage of 78.01 ± 0.09% and, 74.58 ± 0.03% respectively. The inhibi-
tion percentage of 93.04 ± 0.03% was found for neostigmine, the efficient short-term reversible
inhibitor of the AChE enzyme, used as a positive control. The compounds isolated from A.
panurensis revealed promising IC50 values of 19.55μM for 5-N-methylmaytenine and 61.24μM
for stepharine, the IC50 of 3.72μM was observed for neostigmine (Table 1).
Cytotoxicity assay
The compounds were screened for anticancer activity against three cancerous cell lines K562
(human chronic myelogenous leukemia), U937 (human histiocytic lymphoma), and HL60
(human acute promyelocytic leukemia). The compounds demonstrated a good
Fig 3. Binding sites of the IL-8 monomer according to [78–80] (A) and IL-8 dimer structure (B).
https://doi.org/10.1371/journal.pone.0239364.g003
Table 1. Cytotoxic and AChE inhibitory activity of (1) and (2).
Compounds IC50 (μM)
Cell lines AChE
K562 U937 HL60
5-N-methylmaytenine 12.5 11.77 >100 19.55
Stepharine 28.48 19.97 >100 61.24
Neostigmine (positive control, AChE) n/a n/a n/a 3.72
n/a–not applicable
https://doi.org/10.1371/journal.pone.0239364.t001
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antiproliferative activity against the former two cell lines investigated. None of the compounds
showed cytotoxicity against normal cells of the Vero line and human PBMC. The results for
each compound are summarized in the Table 1.
Immunological assay
The levels of cytokines IL-6 and IL-8 were assessed by ELISA in the supernatant of human
PBMC cells treated with 5-N-methylmaytenine and stepharine. Our results demonstrated that
both 5-N-methylmaytenine and stepharine inhibited the IL-6 production in human PBMC
after 24 hours treatment in levels statistically significant (p = 0.0001), when compared to the
untreated PBMC. However, only stepharine induced significant (p = 0.01) decrease in the IL-8
levels, when compared to the control. It is interesting to note that the IL-8 levels became up-
regulated in comparison to the control, when the concentration of 5-N-methylmaytenine was
doubled to 2×IC50 (Table 1). The results suggest that both 1 and 2 induce the anti-inflamma-
tory modulation, but the effect on the IL-8 expression is dose-dependent in the former case.
Discussion
Spectral data interpretation
Structural formulas of the alkaloids with numbering of atoms are shown in the Fig 4. The MS
and NMR spectra of both alkaloids are found in the S1 File.
Molecular formula of the compound (1) was determined by HRMS in the positive mode as
C26H34N3O2. The
1H NMR data revealed (Fig 4) the presence of two dehydroxylated cinnamic
acid moieties characterized by signals of unsubstituted aromatic rings at δH 7.40 (m, H-7´and
H-7´´) and δH 7.54–7.56 (m, H-5´; H-5´´; H-6´; H-6´´; H-8´; H-8´´; H-9´; H-9´´), as well as
the signals of methylene protons at δH 7.38 (m, H-3´´ or H-3´), δH 7.42 (m, H-3´or H-3´´), δH
6.60 (d, H-2´or H-2´´), and δH 6.63 (d, H-2´´ or H-2´). The presence of an amide group in the
structure was confirmed by the signal at δH 8.12 (-NH). Signals of proton resonances in the ali-
phatic region (δH 1.45–3.20) were also elucidated (S3 and S4 Figs in S1 File).
The presence of two cinnamamide moieties in the structure was confirmed by the HMBC
experiment (Fig 4). The signals at δH 7.38 (m, H-3´´ or H-3´) and δH 7.42 (m, H-3´or H-3´´)
show J3 couplings to the quaternary carbon signals at δC 165.27 (C-1´or C-1´´) and δC 165.32
(C-1´´ or C-1´) indicate a presence of two carbonyls in the structure (S9 and S10 Figs in S1
File). Additionally, the HMBC spectra also showed correlations of the -NH group (δH 8.12)
with the above mentioned carbonyl signals (δC 165.27 and δC 165.32) that confirm the pres-
ence of two cinnamamide moieties.
In the aliphatic region of the 13C NMR spectra (S5 and S8 Figs in S1 File), the presence of a
methyl (δC 42.09) and seven methylene carbons (δC 24–55) was confirmed by DEPT-135 (S13
and S14 Figs in S1 File). The methyl group (δC 42.09) directly linked to the nitrogen in the ali-
phatic chain can be confirmed in the HMBC with the long-distance proton couplings between
the δH 2.16 (s, NCH3) and the methylene carbons at δC 55.26 (C-4) and δC 57.12 (C-6).
Seven well-defined signals of methylene carbons were found in the aliphatic region of the
13C NMR spectrum. The corresponding 1H-13C correlations were confirmed in the HSQC
spectrum (S11 and S12 Figs in S1 File), where isochrony of two hydrogen atoms was demon-
strated by the correlation of the proton resonance at δH 1.47 with two different carbon signals
at δC 24.53 and δC 27.48. Furthermore, the proposed structure was confirmed by the following
1H-1H correlations in the COSY spectrum (Fig 4): δH 2.32 with δH 1.45; δH 2.35 with δH 1.61;
δH 3.18 with δH 1.47, and δH 3.20 with δH 1.61 (S15 and S16 Figs in S1 File).
The MS/MS spectrum of the compound (1) is in agreement with the above NMR data. The
ionm/z 420 showed sequential losses of 218 Da (m/z 202), 14 Da (m/z 188), and 57 Da (m/z
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131) (S1 Fig in S1 File), typical for the fragmentation pattern of cinnamic acid amides [46, 59].
Therefore, the compound (1) was identified as 5-N-methylmaytenine, i.e. 1,10-di-E-cinnama-
mide of 5-N-methylspermidine.
The compound (2) appeared as a light brownish amorphous solid. The molecular formula
was determined by HRMS in positive mode as C18H20NO3. The MS/MS spectrum of them/z
298 ion showed sequential losses of 17 Da (m/z 281) and 15 Da (m/z 266), and a loss of 31 Da
(m/z 281! 250) (S17 Fig in S1 File); which are consistent with aporphine alkaloids containing
adjacent methoxyls in the ring A and the non-substituted ring D [60, 81] (Fig 4).
The 1H NMR spectrum is in agreement with the MS data. It exhibited signals typical for
proaporphine alkaloids at δH 2.52 (dd; 6.6 and 12 Hz; H-7 or H-7´), δH 2.42 (dd; 10.5 and 12
Hz; H-7´or H-7), δH 3.02 (m; H-4), δH 3.44 (ddd; 6.3, 11, and 13 Hz; H-5 or H-5´) e δH 3.70
(ddd; 1.5, 6.3, and 13 Hz; H-5´or H-5). The following signals were observed in the range of
aromatic proton resonances: δH 6.89 (s, H-3) corresponding to an orto-substituted ring A; δH
7.16 (dd; 3 and 10 Hz; H-8), δH 6.29 (d; 1.8 and 10 Hz; H-9), δH 6.41 (dd; 1.8 and 10 Hz; H-
11), and δH 7.01 (dd; 3 and 10 Hz; H-12) characteristic of the unsubstituted ring D; and two
signals δH 3.61 (s, 3H) and δH 3.82 (s, 3H) of the methoxy-substituents in the ring A (Fig 4 and
S19-S21 Figs in S1 File).
Fig 4. 5-N-methylmaytenine (1) and stepharine (2). Principal couplings are shown with arrows: HMBC–blue, COSY–red.
https://doi.org/10.1371/journal.pone.0239364.g004
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The proaporphine alkaloid structure was proposed based on the HMBC experiments (Fig
4). The signals at δH 7.16 (dd; 3 and 10 Hz; H-8) and δH 7.01 (dd; 3 and 10 Hz; H-12) showed a
J3-coupling to the carbon at δC 186.6 (C-10). The proaporphine skeleton was also established
following long-distance 1H-13C couplings of the signals at δH 6.89 (s, H-3) and those of the
methoxyls at δH 3.61 (s, 3H) and δH 3.82 (s, 3H) with the carbons at δC 144.6 (C-1) and δC
154.7 (C-2), thus confirming the existence of two substitutions in the A ring (S24 and S25 Figs
in S1 File). Therefore, the compound (2) was elucidated as being the proaporphine alkaloid
stepharine.
The compounds were identified by a comparison of the obtained spectral results with data
reported in the literature [46, 59, 82]. The alkaloid (1) was identified as 5-N-methylmaytenine,
this is the first report on isolation of this compound from a natural product, as well as the first
occurrence of the alkaloid in the Menispermaceae family [59].
The proaporphine alkaloid stepharine (2) was also described by us for the first time in A.
panurensis. Previously, its presence was reported in Stephania genus [83–89], as well as in
some Abuta species [4, 15].
Acetylcholinesterase inhibition
The docking study provided a very useful tool in the interpretation of the AChE inhibitory
activity results, indicating that molecules under investigation were able to bind effectively to
the TcAChE enzyme active site.
The neostigmine (used as a positive control in the assay) forms π-stacking interactions with
the aromatic rings of amino acids from the so-called anionic subsite of the enzyme corre-
sponding to the choline-binding pocket (Trp84 and Phe330). The stronger one is formed with
the phenyl ring of Trp84 (3.66 Å). The stacking distance to Phe330 is 4.31 Å implying a weaker
interaction. There exist two attractive Coulomb interactions as well. The first one is between
the positively charged quaternary ammonium nitrogen and a carboxylic group of the Glu199.
The second interaction is formed between the same charged nitrogen atom and a phenyl ring
of the Trp84, at a distance of approximately 4.4 Å, typical for tetraalkylammonia–π interac-
tions [90] (Fig 5).
Because the active site pocket of the acetylcholinesterase forms a deep and narrow gorge,
formed of aromatic residues by 40% [91], the hydrophobic interactions play a major role in
binding of the compounds under investigation to the AChE (Figs 5 and 6). Docking data indi-
cate that (1) is a plausible ligand for the AChE, which can adopt a variety of binding poses due
to its conformational flexibility. One of the cinnamic acid phenyls is sandwiched between two
aromatic residues of the enzyme Trp84 and Phe330 at the distance of 3.6Å. . .3.9Å that is
slightly above a typical value for a parallel displaced π-stacking. Interactions with peripheral
subsites Tyr121 and Gly117 were also observed. Stepharine (2) fits well inside the AChE pocket
with the predicted binding affinity of -10.3 kcal/mol. This energy corresponds to substantial
interaction between the ligand and the enzyme. (Fig 6). π-Stacking is again the major protein-
ligand interaction for this compound (3.66 Å with Trp84 pyrrole and 4.09 Å with Phe330 phe-
nyl rings). Both alkaloids have their binding poses at the lipophilic anionic subsite (Trp84 and
Phe330) of the TcAChE (Fig 6), where they are able to interact with the enzyme pocket [91,
92].
Overall, all three compounds studied (1, 2, and neostigmine) have phenyl rings as the most
important structural features that lead to similar interactions guiding their affinity towards the
AChE. The preferential interaction of the neostigmine quaternary nitrogen with the π elec-
trons of the aromatic rings at the binding site of the enzyme indicates greater affinity of that
subsite towards easily polarizable ammonium ligands. [93]. The alkaloids in question have no
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such moieties, which can be a reason for higher IC50 values of the 1 and 2, than that of
neostigmine.
Peripheral anionic binding site of the enzyme is also associated with the AChE-mediated
abnormal β-amyloid protein aggregation in Alzheimer’s disease patients [94, 95]. It is interest-
ing to note that owing to a conformational flexibility of the molecule, 5-N-methylmaytenine
interacts simultaneously with both the anionic and the peripheral subsites of the enzyme.
Therefore, (1) may well be capable to have greater pharmacological potential [94], when com-
pared to stepharine that interacts with the anionic active subsite only.
Currently, natural products constitute one of the main sources of the AChE inhibitors, used
as active compounds to treat damages to central and peripheral nervous system, as well as to
alleviate symptoms of neurodegenerative diseases [28, 96, 97]. Bisbenzylisoquinoline and pro-
toberberine alkaloids exhibit a moderate AChE enzyme inhibition potential with IC50 values
in the range of 34.66μM to 78.22μM [17] and 36.6μM to 141.8μM [98], respectively. Whereas
aporphine and proaporphine alkaloids demonstrate better AChE inhibitory activity with the
Fig 5. Neostigmine interactions with the AChE binding pocket.
https://doi.org/10.1371/journal.pone.0239364.g005
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IC50 values ranging from 2.98μM to 20.4μM and this effect is often related to different substitu-
ents in their structure [27]. Polyamine alkaloids such as putrescine, spermidine, spermine,
cadaverine, and their derivatives are present ubiquitously in all living cells; they have a variety
of functions inside the cell, including the cell growth and regeneration [99]. For the central
nervous system in particular, studies show that polyamines act on receptors related to neuro-
degenerative processes [100, 101]. For example, the spermidine decreases significantly the
AChE activity, oxidative stress and neuroinflammation in a cerebral hippocampus [102].
Our study of two alkaloids first obtained from A. panurensis revealed that both compounds
are promising AChE enzyme inhibitors. The capability of 5-N-methylmaytenine to interact
simultaneously with several subsites in the enzyme structure may provide an important guide-
line in the search for new active compounds for treatment of neurological disorders [103].
Cytotoxicity assay
Effectiveness of 5-N-methylmaytenine (Fig 7) and stepharine (Fig 8) in different concentra-
tions were evaluated against U937 and K562 tumor cell lines. The U937 cells were more sus-
ceptible to the stepharine anticancer action. Interestingly, the stepharine demonstrated higher
cytotoxic activity against the K562 strain only in the first 24 hours of treatment. This result
suggest that K562 cell line is more resistant to the stepharine treatment than U937. Both com-
pounds showed practically no toxicity to non-cancerous cells (Vero and human PBMC, Fig 9).
Although stepharine showed greater stability of action in the course of the assay, the 5-N-
methylmaytenine demonstrated higher efficiency, according to the IC50 values.
The results obtained corroborate well with the literature reports that isoquinoline alkaloids
of different backbones, such as berberine and aporphine ones containing an oxo-substituent
in their structure, particularly oxoisoaporphines, demonstrate moderate to strong potential for
cytotoxic activity against several tumor cell lines, including those used in the present work [96,
104–107].
Fig 6. Binding poses (A, B) of the alkaloids inside the AChE pocket and their binding modes (C, D). 5-N-
methylmaytenine (A, C) and stepharine (B, D).
https://doi.org/10.1371/journal.pone.0239364.g006
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Immunomodulatory assay
The anti-inflammatory properties of acetylcholinesterase inhibitors are mediated by a cholin-
ergic system present in the immune cells [108, 109]. For instance, macrophages and T cells
express α7 homopentameric nAChR receptor that can down-regulate the production of
inflammatory cytokines (TNF-α and IL-1β) and NF-κB-dependent transcription, when stimu-
lated [110]. The latter pathway regulation may be involved in the pathogenesis of many
chronic diseases such as asthma, rheumatoid arthritis, atherosclerosis, and even though the
Alzheimer’s disease [111–113]. In this study, we did not assess the potential of stepharine and
5-N-methylmaytenine in regulating the NF-κB immune pathway. However, our findings dem-
onstrate that the cholinergic anti-inflammatory pathway could reduce the production of IL-6
and IL-8 owing to the AChE inhibitor treatment, which can protect against the damage pro-
voked by inflammation in different types of inflammatory diseases.
According to the molecular docking studies, both alkaloids bind to the interleukins with
quite similar affinity in the range of -8 . . .-6 kcal/mol.
Binding to the IL-6. In the case of IL-6, 5-N-methylmaytenine binds to the upper rim of
the protein (Fig 10), giving rise to hydrogen bonds with carboxylic groups of Glu36 (modeled
loop, 2.20 Å) and Asp145 (1.94 Å). A weak cation-π interaction with Arg89 guanidine moiety
and favorable hydrophobic interactions between the phenyl ring of 1 and carbon chains of
Leu42 and Lys39 were also formed.
Fig 7. Cytotoxic activity of 5-N-methylmaytenine respective IC50 values.
https://doi.org/10.1371/journal.pone.0239364.g007
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Similarly, stepharine (2) binds to the top region of the IL-6 interacting with Met146 of the
α-helix (π-sulfur interaction at 3.65 Å) and with Glu36 of the modeled loop (weak anion-π
interaction with the carboxyl group).
Both alkaloids interact with the Site 3 of the IL-6 (Fig 2) indicating that they are able to dis-
rupt IL-6 –gp130 complex formation and thus hinder the signaling. Results of the immunolog-
ical assay are in agreement with the above statement (Fig 11).
Binding to IL-8. According to the docking results, both alkaloids bind into a shallow
pocket between a Thr12 –Pro19 loop and a β-sheet region Ile40 –Cys50 (Fig 12), which are
close to the receptor-binding Site I (Fig 3); implying inhibitory action of both 1 and 2. 5-N-
methylmaytenine forms an aromatic interaction with the Phe21 phenyl ring and two π-charge
interactions with the Arg47 guanidine moiety of and the Asp45 carboxyl group. Stepharine
binds to the protein pocket in a similar way by π-π stacking interaction with Phe21, but acts as
a hydrogen-bond acceptor for the -NH proton of Arg47 (Fig 12). This fact may suggest a
slightly stronger inhibition of IL-8 production by stepharine. In the case of 5-N-methylmayte-
nine, the induction of the IL-8 level downregulation seems to happen in a dose-dependent
manner (Fig 11).
It was shown that some interleukins, including the IL-8, can exist both as dimers and
monomers in solution [78]. The dimerization occurs at higher IL-8 concentrations and is
highly sensitive to solution conditions such as pH and ionic strength [114, 115]. In general,
affinity to the receptors and activity of the dimers are much lower than those of the monomers
Fig 8. Cytotoxic activity of stepharine and respective IC50 values.
https://doi.org/10.1371/journal.pone.0239364.g008
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[114, 116]. We conducted docking studies of 5-N-methylmaytenine and stepharine to the IL-8
dimer (Fig 13).
Affinities of the 1 and 2 to the dimer are similar to those of the monomeric protein: -7.0
kcal/mol for 1 and -5.9 kcal/mol for 2. Inclusion of water molecules into the dimer structure
did not lead to improvement of binding affinities. It is interesting to note that binding posi-
tions of the two ligands became different. While stepharine binds to the dimer the same way as
it interacts with the monomer (Fig 12), the 5-N-methylmaytenine molecule is stretched
between α-helices and interacts with both monomer moieties. Most of the direct interactions
were found with one of the IL-8 units, viz., two hydrogen bonds with oxygen atoms of Asn71
and Glu70 (2.71 Å and 2.38 Å, respectively) and a weak anion-π interaction between the phe-
nyl ring of 1 and a carboxylic group of Glu63 (3.85 Å). Carbon chains of Lys54 and Leu66 of
another IL-8 molecule form hydrophobic interactions with the phenyl rings of 5-N-methyl-
maytenine. At lower concentrations, 1 is able to interact with the IL-8 dimers and possibly to
prevent their dissociation into more active monomer form. At higher concentrations, the
binding of 5-N-methylmaytenine to the IL-8 monomers and their activation may take place.
Mostly, IL-6 and IL-8 play a crucial role in the selective chemotaxis, degranulation, and
activation of neutrophils. High levels of those interleukins are associated with an immuno-
pathogenesis of many chronic inflammation diseases, such as cell injury in kidney inflamma-
tion, poor outcome of different neurological manifestations, and excessive infiltration of
neutrophils in airways of cystic fibrosis patients [117–119]. Thus, therapies targeting pro-
inflammatory cytokines, such as IL-6 and IL-8, have important clinical implications.
Fig 9. Cytotoxicity assessment of the alkaloids to Vero and human PBMC cells. Stepharine (A, C) and 5-N-methylmaytenine (B, D).
https://doi.org/10.1371/journal.pone.0239364.g009
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Conclusion
This is the first paper dealing with 5-N-methylmaytenine isolation from natural products and
the first report on the occurrence of both 5-N-methylmaytenine and stepharine alkaloids in
branches of the Amazonian plant Abuta panurensis. Inhibitory activity of both alkaloids
towards the AChE enzyme was evaluated by spectrophotometry and molecular docking study.
Fig 10. Binding poses (A) of the alkaloids at the IL-6 and their binding modes (B, C). 5-N-methylmaytenine (blue
A, B) and stepharine (green A, C).
https://doi.org/10.1371/journal.pone.0239364.g010
Fig 11. Immunomodulatory effect of 5-N-methylmaytenine and stepharine.
https://doi.org/10.1371/journal.pone.0239364.g011
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The compounds in question bind effectively to the enzyme active site and demonstrate prom-
ising inhibitory potential. Owing to the greater conformational flexibility of 5-N-methylmayte-
nine, it is capable to interact with both anionic and peripheral subsites, thus demonstrating
higher AChE inhibition potential, when compared to stepharine.
Both alkaloids were effective against K562 and U937 tumor cells, showing practically no
toxicity to normal cell lines Vero and human PBMC.
5-N-methylmaytenine and stepharine demonstrated immunomodulatory activity towards
IL-6 and IL-8 interleukins. In the former case, both alkaloids inhibited the IL-6 production at
very similar levels, which may probably be related to the formation of hydrogen bonds with
the protein binding sites. In the latter case, stepharine inhibited considerably the production
of IL-8 in comparison to 5-N-methylmaytenine that showed a dose dependent action (inhibi-
tory at the IC50 dose, and stimulatory at the twofold IC50 one). Such a behavior may possibly
Fig 12. Binding poses (A, B) of the alkaloids at the IL-8 and their binding modes (C, D). 5-N-methylmaytenine (A, C) and stepharine (B, D).
https://doi.org/10.1371/journal.pone.0239364.g012
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be explained by different binding modes of the alkaloids to the interleukin monomer and
dimer forms.
Our results suggest that 5-N-methylmaytenine and stepharine could be used as reversible
AChE inhibitors in the treatment of neurological disorder manifestations, as well as candidate
immunomodulatory agents in the inflammatory disease context. However, more research is
necessary to better investigate the complete pharmacological potential and toxicological profile
of these compounds.
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Ingrity Suelen Costa Sá, Gabriel Coutinho Borges Camargo, Andriy Grafov.
Methodology: Gemilson Soares Pontes, Felipe Moura Araújo da Silva.
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18. Ginaudeau H, Leboeuf M, Cavé A. Aporphine alkaloids. II. J Nat Prod. 1979; 42: 325–360. https://doi.
org/10.1021/np50004a001 PMID: 5879291
19. Swaffar DS, Holley CJ, Fitch RW, Elkin KR, Zhang C, Sturgill JP, et al. Phytochemical investigation
and in vitro cytotoxic evaluation of alkaloids from abuta rufescens. Planta Med. 2012; 78: 230–232.
https://doi.org/10.1055/s-0031-1280383 PMID: 22109836
20. Cava MP, Buck K T, Noguchi I, Srinivasan M, Rao MG. The alkaloids of Abuta imene and Abuta rufes-
cens. Tetrahedron. 1975; 31: 4–6.
21. Murebwayire S, Ingkaninan K, Changwijit K, Frédérich M, Duez P. Triclisia sacleuxii (Pierre) Diels
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